Agios Pharmaceuticals
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 60 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 64 % · cci-v1
11 active sensors·3 observations·0 historical changes·0 structured events·historical coverage 79 %·observed since 2026-09-13
Compare Agios Pharmaceuticals with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
